Validation of an Egyptian Arabic Version of Skindex-16 and Quality of Life Measurement in Egyptian Patients with Skin Disease.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Essa N;Essa N; Awad S; Awad S; Nashaat M; Nashaat M
  • Source:
    International journal of behavioral medicine [Int J Behav Med] 2018 Apr; Vol. 25 (2), pp. 243-251.
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Informa Healthcare Country of Publication: England NLM ID: 9421097 Publication Model: Print Cited Medium: Internet ISSN: 1532-7558 (Electronic) Linking ISSN: 10705503 NLM ISO Abbreviation: Int J Behav Med Subsets: MEDLINE
    • Publication Information:
      Publication: London : Informa Healthcare
      Original Publication: Hillsdale, NJ : Lawrence Erlbaum Associates, c1994-
    • Subject Terms:
    • Abstract:
      Purpose: To translate and cross-culturally adapt the Skindex-16, a brief skin-disease-specific QoL questionnaire, into Arabic for Egyptians and to evaluate its measurement properties in Egyptian patients with skin disease.
      Method: Translation and cultural adaption were performed following guidelines for cross-cultural adaption of health-related quality of life measures. Subsequently, Skindex-16 was administered to 500 consecutive dermatological patients and 500 healthy persons for verification of its reliability and validity. Next, we examined the effect of skin disorders on QoL as well as influences of age, sex, socioeconomic level, education, and use of medication on skin disease-related QoL.
      Results: The instrument showed high internal consistency reliability and good construct and content validity. The quality of life was most deteriorated in the emotional domain followed by symptoms domain (mean percentage score 55.5 ± 23.1 and 31.7 ± 26.8 respectively), while functioning was the least affected domain (mean percentage score 29.1 ± 26.8). Higher total Skindex-16 scores were observed for patients with psoriasis, urticaria, acne, and atopic dermatitis than those with vitiligo and alopecia areata. Educational level, social class, medication use, and family history influenced the impact of skin disease on overall QoL.
      Conclusion: The adapted Egyptian Arabic version of Skindex-16 is valid and reliable; it showed that skin problems had a clinically significant impact on QoL in Egyptian patients.
    • References:
      Ann Intern Med. 1978 Feb;88(2):251-8. (PMID: 626456)
      Clin Exp Dermatol. 1994 May;19(3):210-6. (PMID: 8033378)
      J Clin Epidemiol. 1993 Dec;46(12):1417-32. (PMID: 8263569)
      Qual Life Res. 2010 May;19(4):539-49. (PMID: 20169472)
      G Ital Dermatol Venereol. 2016 Feb;151(1):37-43. (PMID: 24927171)
      J Invest Dermatol. 2010 May;130(5):1318-22. (PMID: 20032989)
      J Invest Dermatol. 2013 Jan;133(1):104-9. (PMID: 22832497)
      Int J Dermatol. 2000 Nov;39(11):826-31. (PMID: 11123442)
      Health Qual Life Outcomes. 2014 Dec 24;12:190. (PMID: 25539748)
      Int J Gen Med. 2012;5:633-42. (PMID: 22866015)
      Indian J Dermatol. 2015 Nov-Dec;60(6):635. (PMID: 26677293)
      Eur J Dermatol. 2012 Sep-Oct;22(5):672-7. (PMID: 22947338)
      BMC Dermatol. 2011 Dec 19;11:16. (PMID: 22182399)
      Br J Dermatol. 2009 Jul;161(1):134-9. (PMID: 19298268)
      Saudi Med J. 2007 Sep;28(9):1414-7. (PMID: 17768471)
      Acta Derm Venereol. 2004;84(3):205-12. (PMID: 15202837)
      Dermatol Clin. 2012 Apr;30(2):231-6, xiii. (PMID: 22284137)
      J Dermatolog Treat. 2014 Apr;25(2):106-9. (PMID: 22455447)
      Int J Dermatol. 2005 Nov;44(11):933-8. (PMID: 16336527)
      Acta Derm Venereol. 2000 Nov-Dec;80(6):430-4. (PMID: 11243637)
      Br J Dermatol. 1999 Apr;140(4):667-71. (PMID: 10233318)
      Int J Dermatol. 2000 Dec;39(12):907-12. (PMID: 11168659)
      Br J Dermatol. 1997 Mar;136(3):305-14. (PMID: 9115906)
      Acta Med Iran. 2012;50(7):511-5. (PMID: 22930385)
      J Dtsch Dermatol Ges. 2005 Jun;3(6):431-5. (PMID: 15892845)
      Int J Dermatol. 2011 Oct;50(10):1249-54. (PMID: 21950290)
      J Am Acad Dermatol. 2009 Feb;60(2):261-9. (PMID: 19004524)
      J Dermatol. 2002 Nov;29(11):693-8. (PMID: 12484430)
      Arch Dermatol. 1997 Nov;133(11):1433-40. (PMID: 9371029)
      Int J Dermatol. 2007 Mar;46(3):247-52. (PMID: 17343578)
      BMJ. 1997 Feb 22;314(7080):572. (PMID: 9055718)
      Mycoses. 2009 Jul;52(4):357-63. (PMID: 18793259)
      J Cutan Med Surg. 2001 Mar-Apr;5(2):105-10. (PMID: 11443481)
      Int J Dermatol. 2008 Mar;47(3):236-41. (PMID: 18289322)
      Clin Exp Dermatol. 2002 Jun;27(4):306-8. (PMID: 12139677)
      Br J Dermatol. 2005 Feb;152(2):289-95. (PMID: 15727641)
      Arch Dermatol. 1998 Apr;134(4):454-8. (PMID: 9554297)
      Psychosom Med. 1995 May-Jun;57(3):245-54. (PMID: 7652125)
      J Invest Dermatol. 1996 Nov;107(5):707-13. (PMID: 8875954)
      Acta Dermatovenerol Alp Pannonica Adriat. 2009 Dec;18(4):157-64. (PMID: 20043053)
      Br J Rheumatol. 1990 Jun;29(3):193-6. (PMID: 2357501)
      Clinics (Sao Paulo). 2007 Jun;62(3):235-42. (PMID: 17589662)
    • Contributed Indexing:
      Keywords: Egyptian version; Quality of life; Skin diseases; Skindex-16
    • Publication Date:
      Date Created: 20170728 Date Completed: 20190103 Latest Revision: 20190103
    • Publication Date:
      20240105
    • Accession Number:
      10.1007/s12529-017-9677-9
    • Accession Number:
      28748378